222 related articles for article (PubMed ID: 30987427)
1. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin.
Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ
Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin.
Liu X; St Ange K; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Chi L; Jin C; Jin Y; Yao Y; Linhardt RJ
Clin Appl Thromb Hemost; 2017 Sep; 23(6):542-553. PubMed ID: 28056526
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
[TBL] [Abstract][Full Text] [Related]
4. Parent heparin and daughter LMW heparin correlation analysis using LC-MS and NMR.
Liu X; St Ange K; Wang X; Lin L; Zhang F; Chi L; Linhardt RJ
Anal Chim Acta; 2017 Apr; 961():91-99. PubMed ID: 28224913
[TBL] [Abstract][Full Text] [Related]
5. [Determination of sulfation degree of heparin and low molecular weight heparins by capillary electrophoresis].
Shen Y; Kang J
Se Pu; 2020 Oct; 38(10):1238-1242. PubMed ID: 34213122
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
Chen Y; Zhao J; Yu Y; Liu X; Lin L; Zhang F; Linhardt RJ
J Pharm Sci; 2018 May; 107(5):1290-1295. PubMed ID: 29339133
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
[TBL] [Abstract][Full Text] [Related]
8. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
[TBL] [Abstract][Full Text] [Related]
9. Top-down and bottom-up analysis of commercial enoxaparins.
Liu X; St Ange K; Lin L; Zhang F; Chi L; Linhardt RJ
J Chromatogr A; 2017 Jan; 1480():32-40. PubMed ID: 28011077
[TBL] [Abstract][Full Text] [Related]
10. Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin.
Olson G; Jeske W; Iqbal O; Krupa E; Farooqui A; Siddiqui F; Hoppensteadt D; Kouta A; Fareed J
Clin Appl Thromb Hemost; 2023; 29():10760296231163251. PubMed ID: 36908199
[No Abstract] [Full Text] [Related]
11. Structural characterization of pharmaceutical heparins prepared from different animal tissues.
Fu L; Li G; Yang B; Onishi A; Li L; Sun P; Zhang F; Linhardt RJ
J Pharm Sci; 2013 May; 102(5):1447-57. PubMed ID: 23526651
[TBL] [Abstract][Full Text] [Related]
12. Generic low-molecular-weight heparins: some practical considerations.
Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
[TBL] [Abstract][Full Text] [Related]
13. Chemometric analysis of porcine, bovine and ovine heparins.
Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
[TBL] [Abstract][Full Text] [Related]
14. Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.
Xu X; Li D; Chi L; Du X; Bai X; Chi L
Carbohydr Res; 2015 Apr; 407():26-33. PubMed ID: 25701653
[TBL] [Abstract][Full Text] [Related]
15. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy.
Smith RE; Townsend GE; Berry BR; Bowen T
Ann Pharmacother; 1996 May; 30(5):476-80. PubMed ID: 8740327
[TBL] [Abstract][Full Text] [Related]
16. Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer.
Walenga JM; Lyman GH
Crit Rev Oncol Hematol; 2013 Oct; 88(1):1-18. PubMed ID: 23849978
[TBL] [Abstract][Full Text] [Related]
17. A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin.
Zhang B; Shi D; Li M; Shi F; Chi L
Carbohydr Polym; 2023 Feb; 301(Pt A):120303. PubMed ID: 36436866
[TBL] [Abstract][Full Text] [Related]
18. Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin.
Gibson JL; Ekevall K; Walker I; Greer IA
Br J Obstet Gynaecol; 1998 Jul; 105(7):795-7. PubMed ID: 9692422
[TBL] [Abstract][Full Text] [Related]
19. Chemobiocatalytic Synthesis of a Low-Molecular-Weight Heparin.
Yu Y; Fu L; He P; Xia K; Varghese S; Wang H; Zhang F; Dordick J; Linhardt RJ
ACS Chem Biol; 2022 Mar; 17(3):637-646. PubMed ID: 35201757
[TBL] [Abstract][Full Text] [Related]
20. Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments.
Davenport A
Nephrology (Carlton); 2009 Aug; 14(5):455-61. PubMed ID: 19674314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
